(Q48193560)

9 February 2018

title

Peptides and anxiety: a dose-response evaluation of pentagastrin in healthy volunteers. (English)

1 reference

9 February 2018

author name string

McCann UD

1

1 reference

9 February 2018

Slate SO

2

1 reference

9 February 2018

Geraci M

3

1 reference

9 February 2018

Uhde TW

4

1 reference

9 February 2018

publication date

1 January 1994

1 reference

9 February 2018

published in

Anxiety

1 reference

9 February 2018

volume

1

1 reference

9 February 2018

issue

6

1 reference

9 February 2018

page(s)

258-267

1 reference

9 February 2018

Pentagastrin infusions in patients with panic disorder. I. Symptoms and cardiovascular responses.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010603

Pentagastrin infusions in patients with panic disorder II. Neuroendocrinology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010603

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010603

Comparative distribution of cholecystokinin and other neuropeptides. Why is this peptide different from all other peptides?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010603

Cholecystokinin octapeptide: continuous picomole injections into the cerebral ventricles of sheep suppress feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010603

Further analysis of the effects of cholecystokinin octapeptides on avoidance behaviour in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010603

CCK in animal and human research on anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010603

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010603

Evaluation of the effects of PD 134308 (CI-988), A CCK-B antagonist, on the punished responding of squirrel monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010603

'Anxiolytic' effect of CCK-antagonists on plus-maze behavior in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010603

Cholecystokinin and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010603

Failure of intravenous pentagastrin challenge to induce panic-like effects in rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010603

The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010603

Evidence for an involvement of the brain cholecystokinin B receptor in anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010603

Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010603

A Rating Instrument For Anxiety Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010603

21 January 2018

Identifiers

DOI

10.1002/ANXI.3070010603

1 reference

9 February 2018

release_7yd7jny2rrduxgq3dmg4grlqse

Fatcat ID

0 references

PubMed ID

9160584

1 reference

9 February 2018